NNOX Stock Analysis: Buy, Sell, or Hold?
NNOX - NANO-X IMAGING LTD Ordinary Shares
$1.67
-0.06 (-3.47%)
▼
5d:
-2.34%
30d:
-3.47%
90d:
-33.47%
HOLD
MODERATE Confidence
Analysis Updated: Jun 18, 2026 12:00 AM ET
Earnings: Apr 20, 2026
0d
Get Alerted When NNOX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NNOX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NNOX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NNOX is currently trading at $1.67, which is considered oversold relative to its 30-day fair value range of $1.69 to $1.93.
Technical Outlook: Technically, NNOX is in a strong downtrend. The price is currently testing key support at $1.67. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: NNOX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.20 (+331.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NNOX is in a strong downtrend. The price is currently testing key support at $1.67. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: NNOX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.20 (+331.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.69 -
$1.93
Company Quality Score
50/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
56.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.5%)
- BULLISH: Trading 331.1% below Wall St target ($7.20)
Trading Range Analysis
30-Day Trading Range
$1.69 -
$1.93
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.26
(15.6%)
Support & Resistance Levels
Support Level
$1.67
Resistance Level
$2.10
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.35
Wall Street Target
$7.20
(+331.1%)
Revenue Growth (YoY)
24.0%
Share & Embed Analysis
Last updated: June 19, 2026 11:03 AM ET
Data refreshes hourly during market hours. Next update: 12:03 PM
Data refreshes hourly during market hours. Next update: 12:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NNOX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 51 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 52 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 60 HOLD |
